1
|
Cross SS, Hamdy FC, Deloulme JC and Rehman
I: Expression of S100 proteins in normal human tissues and common
cancers using tissue microarrays: S100A6, S100A8, S100A9 and
S100A11 are all overexpressed in common cancers. Histopathology.
46:256–269. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang XH, Zhang LH, Zhong XY, Xing XF, Liu
YQ, Niu ZJ, Peng Y, Du H, Zhang GG, Hu Y, et al: S100A6
overexpression is associated with poor prognosis and is
epigenetically up-regulated in gastric cancer. Am J Pathol.
177:586–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Filipek A and Kuźnicki J: Calcyclin-from
basic research to clinical implications. Acta Biochim Pol.
40:321–327. 1993.PubMed/NCBI
|
4
|
Shekouh AR, Thompson CC, Prime W, Campbell
F, Hamlett J, Herrington CS, Lemoine NR, Crnogorac-Jurcevic T,
Buechler MW, Friess H, et al: Application of laser capture
microdissection combined with two-dimensional electrophoresis for
the discovery of differentially regulated proteins in pancreatic
ductal adenocarcinoma. Proteomics. 3:1988–2001. 2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Brown LM, Helmke SM, Hunsucker SW,
Netea-Maier RT, Chiang SA, Heinz DE, Shroyer KR, Duncan MW and
Haugen BR: Quantitative and qualitative differences in protein
expression between papillary thyroid carcinoma and normal thyroid
tissue. Mol Carcinog. 45:613–626. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Stulik J, Osterreicher J, Koupilová K,
Knízek J, Bures J, Jandík P, Langr F, Dedic K, Schäfer BW and
Heizmann CW: Differential expression of the Ca2+ binding
S100A6 protein in normal, preneoplastic and neoplastic colon
mucosa. Eur J Cancer. 36:1050–1059. 2000. View Article : Google Scholar : PubMed/NCBI
|
7
|
Komatsu K, Kobune-Fujiwara Y, Andoh A,
Ishiguro S, Hunai H, Suzuki N, Kameyama M, Murata K, Miyoshi J,
Akedo H, et al: Increased expression of S100A6 at the invading
fronts of the primary lesion and liver metastasis in patients with
colorectal adenocarcinoma. Br J Cancer. 83:769–774. 2000.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Weterman MA, Stoopen GM, van Muijen GN,
Kuznicki J, Ruiter DJ and Bloemers HP: Expression of calcyclin in
human melanoma cell lines correlates with metastatic behavior in
nude mice. Cancer Res. 52:1291–1296. 1992.PubMed/NCBI
|
9
|
Pedrocchi M, Schafer BW, Mueller H,
Eppenberger U and Heizmann CW: Expression of Ca
(2+)-binding proteins of the S100 family in malignant
human breast-cancer cell lines and biopsy samples. Int J Cancer.
57:684–690. 1994. View Article : Google Scholar : PubMed/NCBI
|
10
|
Rehman I, Cross SS, Catto JW, Leiblich A,
Mukherjee A, Azzouzi AR, Leung HY and Hamdy FC: Promoter
hyper-methylation of calcium binding proteins S100A6 and S100A2 in
human prostate cancer. Prostate. 65:322–330. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Rehman I, Cross SS, Azzouzi AR, Catto JW,
Deloulme JC, Larre S, Champigneuille J, Fromont G, Cussenot O and
Hamdy FC: S100A6 (Calcyclin) is a prostate basal cell marker absent
in prostate cancer and its precursors. Br J Cancer. 91:739–744.
2004.PubMed/NCBI
|
12
|
Kim J, Kim J, Yoon S, Joo J, Lee Y, Lee K,
Chung J and Choe I: S100A6 protein as a marker for differential
diagnosis of cholangiocarcinoma from hepatocellular carcinoma.
Hepatol Res. 23:2742002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lyu X, Li H, Ma X, Li X, Gao Y, Ni D, Shen
D, Gu L, Wang B, Zhang Y and Zhang X: High-level S100A6 promotes
metastasis and predicts the outcome of T1-T2 stage in clear cell
renal cell carcinoma. Cell Biochem Biophys. 71:279–290. 2015.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Emberley ED, Murphy LC and Watson PH: S100
proteins and their influence on pro-survival pathways in cancer.
Biochem Cell Biol. 82:508–515. 2004. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Golitsina NL, Kordowska J, Wang CL and
Lehrer SS: Ca2+-dependent binding of calcyclin to muscle
tropomyosin. Biochem Biophys Res Commun. 220:360–365. 1996.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Mani RS, McCubbin WD and Kay CM:
Calcium-dependent regulation of caldesmon by an 11-kDa smooth
muscle calcium-binding protein, caltropin. Biochemistry.
31:11896–11901. 1992. View Article : Google Scholar : PubMed/NCBI
|
17
|
Bao L, Odell AF, Stephen SL, Wheatcroft
SB, Walker JH and Ponnambalam S: The S100A6 calcium-binding protein
regulates endothelial cell-cycle progression and senescence. FEBS
J. 279:4576–4588. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Joo JH, Kim JW, Lee Y, Yoon SY, Kim JH,
Paik SG and Choe IS: Involvement of NF-kappaB in the regulation of
S100A6 gene expression in human hepatoblastoma cell line HepG2.
Biochem Biophys Res Commun. 307:274–280. 2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zheng M, Barrera LO, Ren B and Wu YN:
ChIP-chip: Data, model, and analysis. Biometrics. 63:787–796. 2007.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Vimalachandran D, Greenhalf W, Thompson C,
Lüttges J, Prime W, Campbell F, Dodson A, Watson R,
Crnogorac-Jurcevic T, Lemoine N, et al: High nuclear S100A6
(Calcyclin) is significantly associated with poor survival in
pancreatic cancer patients. Cancer Res. 65:3218–3225.
2005.PubMed/NCBI
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Wu H, Weng D, Weng D, Xing H, Song X, Zhu
T, Xia X, Weng Y, Xu G, Meng L, et al: Reversal of the malignant
phenotype of ovarian cancer A2780 cells through transfection with
wild-type PTEN gene. Cancer Lett. 271:205–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Leśniak W, Słomnicki ŁP and Filipek A:
S100A6 - new facts and features. Biochem Biophys Res Commun.
390:1087–1092. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka
H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, et al: IL-8
promotes cell proliferation and migration through
metalloproteinase-cleavage proHB-EGF in human colon carcinoma
cells. Cytokine. 29:275–282. 2005.PubMed/NCBI
|
25
|
Lord JD, McIntosh BC, Greenberg PD and
Nelson BH: The IL-2 receptor promotes lymphocyte proliferation and
induction of the c-myc, bcl-2, and bcl-x genes through the
trans-activation domain of Stat5. J Immunol. 164:2533–2541. 2000.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Henriksson JT, Coursey TG, Corry DB, De
Paiva CS and Pflugfelder SC: IL-13 stimulates proliferation and
expression of mucin and immunomodulatory genes in cultured
conjunctival goblet cells. Invest Ophthalmol Vis Sci. 56:4186–4197.
2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu D, Liu C, Wang X, Ingvarsson S and
Chen H: MicroRNA-451 suppresses tumor cell growth by
down-regulating IL6R gene expression. Cancer Epidemiol. 38:85–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Sherr CJ: The Pezcoller lecture: Cancer
cell cycles revisited. Cancer Res. 60:3689–3695. 2000.PubMed/NCBI
|
29
|
Brinkkoetter PT, Olivier P, Wu JS,
Henderson S, Krofft RD, Pippin JW, Hockenbery D, Roberts JM and
Shankland SJ: Cyclin I activates Cdk5 and regulates expression of
Bcl-2 and Bcl-XL in postmitotic mouse cells. J Clin Invest.
119:3089–3101. 2009. View
Article : Google Scholar : PubMed/NCBI
|
30
|
Padmanabhan V, Callas P, Philips G,
Trainer TD and Beatty BG: DNA replication regulation protein Mcm7
as a marker of proliferation in prostate cancer. J Clin Pathol.
57:1057–1062. 2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bouchard C, Staller P and Eilers M:
Control of cell proliferation by Myc. Trends Cell Biol. 8:202–206.
1998. View Article : Google Scholar : PubMed/NCBI
|
32
|
Słomnicki ŁP, Nawrot B and Leśniak W:
S100A6 binds p53 and affects its activity. Int J Biochem Cell Biol.
41:784–790. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Innocente SA and Lee JM: p53 is a NF-Y-
and p21-independent, Sp1-dependent repressor of cyclin B1
transcription. FEBS Lett. 579:1001–1007. 2005. View Article : Google Scholar : PubMed/NCBI
|